Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Citrate for the Transition From CKD Stage 4/5 to Stage 5D
NCT02492620Phase 3Completed
- Sponsor
- Colorado Kidney Care
- Start
- Mar 2015
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric citrate in chronic kidney disease (CKD), hyperphosphatemia, iron deficiency anemia (IDA), sponsored by Colorado Kidney Care. Started Mar 2015; status: completed.
02
Drugs
ferric citrate
03
Conditions
chronic kidney disease (CKD)hyperphosphatemiairon deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02492620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02492620.